373 views | 7 years ago
Chemical carcinogens induce tumors in all exposed mice and rats, but not the blind mole rat. Furthermore, not a single case of spontaneous tumor development has been recorded among thousands of captive...
372 views | 8 years ago
Grapefruits and Mohawks: The Fountain of Youth? Synopsis: The process of aging has been of interest for millennia. Myths of the fountain of youth still have their allure of longevity. Scientists today...
371 views | 2 years ago
Watch the video to find out why laboratories In Europe have implemented VeriSeq NIPT. Why did they start to think about onboarding NIPT technology? The benefits of introducing Illumina NIPT The benefits...
369 views | 9 years ago
This webinar summarizes the outcome of the Medicare gapfilling process for 114 new molecular pathology (MoPath) codes that were implemented in 2013. The presentation addresses the final 2013 regional...
366 views | 7 years ago
Tony Gordon, Genesis Genomics Managing Director (US) and Lab Director (UK) discusses how the Illumina portfolio empowers reproductive health labs with its ability to run both pre-and postnatal tests...
365 views | 2 years ago
Developing and setting up a new NGS analysis pipeline can be a time and money-consuming venture. Lynn Fink, Lab Director at Xing Cancer Care in Brisbane Australia shares how she uses Illumina’s BaseSpace...
364 views | 6 years ago
Illumina has developed an extensive service network to empower scientists around the world with next-generation sequencing (NGS). http://www.Illumina.com/support Our global, multi-lingual team includes...
363 views | 1 year ago
Moderator: Phil Febbo, Illumina Panelists: Tulio de Oliveira, Nelson Mandela School of Medicine; Stacey Gabriel, The Broad Institute; Scott Gottlieb, New Enterprise Associates; Eric Topol, Scripps Research...